arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Medpace Holdings, Inc.

MEDP Health Care Biotechnology: Commercial Physical & Biological Resarch
$653.96
▲ +5.1% Today
as of Oct 22, 16:50 ET
Last 30 days +9.83% Sep 14 → Oct 22
$590.04 $609.49 $628.94 $648.40 $667.85 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$657.11
High
$684.52
Low
$645.29
Volume
$883,095
Avg Vol
$320,251
Mkt Cap
$16.9B
P/E (TTM)
49.92
Beta
—
52w High
$684.52
52w Low
$373.00
Div Yield
—
Shares Out
$28M

Recent Press Releases & News last 60 days · 25 items

Oct 22 · 15:05 MarketBeat
Medpace Q3 Earnings Call Highlights
Oct 22 · 11:24 MT Newswires
Deutsche Bank Adjusts Medpace Price Target to $650 From $535, Maintains Hold Rating
Oct 21 · 21:33 Investing.com
Medpace beats Q3 estimates but guides below on revenue
▸ Show all 25 press releases & news Free account →

MEDP earnings at a glance

The options market is pricing a move of about ±3.8% after the report, a range of roughly $628.79 to $679.13 from today's $653.96. Over its last 6 reports the stock rose the next day 3 times and fell 3, moving ±19.9% on average; after the most recent report on Jul 22, 2026 it moved +14.7%. That means options currently expect less movement than MEDP has typically delivered. MEDP beat the consensus EPS estimate in 6 of its last 6 reported quarters. Implied volatility is currently 33%. The share price of $653.96 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$373
$685
90% of range
Avg surprise (last 6)
+10.6%
Avg reaction (last 6)
+6.3%
50% positive
Latest IV / EM
33%
EM ±3.8% · $600 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.93$2.62$3.30$3.99$4.67 Actual $2.27Actual $1.93Actual $2.22Actual $3.20Actual $2.75Actual $3.01Actual $3.67Est $3.06Actual $3.10Est $3.00Actual $3.86Est $3.50Actual $4.67Est $4.18Actual $4.28Est $3.74Actual $4.25Est $4.08 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258K8KJun/2026
Revenue vs Net Income Revenue Net income
$0$186M$371M$557M$743M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Jul 22, 2026Jun/2026 $4.25 $4.08 +4.2% +31.6% +14.7% earnings
Wed Apr 22, 20268K 2026-04-22 $4.28 $3.74 +14.4% — -22.6% earnings
Mon Feb 9, 20268K 2026-02-09 $4.67 $4.18 +11.7% — -15.9% earnings
Wed Oct 22, 2025Sep/2025 $3.86 $3.50 +10.3% — +9.1% earnings
Mon Jul 21, 2025Jun/2025 $3.10 $3.00 +3.3% — +54.7% earnings
Mon Apr 21, 2025Mar/2025 $3.67 $3.06 +19.9% — -2.3% earnings
Mon Sep 30, 2024Sep 2024 $3.01 — — — — financials
Sun Jun 30, 2024Jun 2024 $2.75 — — — — financials
Sun Mar 31, 2024Mar 2024 $3.20 — — — — financials
Sat Sep 30, 2023Sep 2023 $2.22 — — — — financials
Fri Jun 30, 2023Jun 2023 $1.93 — — — — financials
Fri Mar 31, 2023Mar 2023 $2.27 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$707M$707M—$660M$603M$559M—$533M
Cost of revenue————————
Gross profit————————
Operating income$147M$142M—$142M$126M$114M—$112M
Net income$121M$124M—$111M$90M$115M—$96M
EPS (diluted)$4.25$4.28—$3.86$3.10$3.67—$3.01

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$503M$653M$497M$285M$46M$441M$669M$657M
Inventory————————
Total current assets$1.05B$1.14B$990M$737M$521M$821M$1.03B$1.03B
Total assets$2.06B$2.13B$1.98B$1.75B$1.57B$1.90B$2.10B$2.08B
Long-term debt————————
Total liabilities$1.62B$1.53B$1.52B$1.46B$1.40B$1.30B$1.28B$1.20B
Total equity$434M$598M$459M$294M$172M$594M$826M$881M

Implied volatility — last 90 days

25%39%52%65%79% Jun 07 — IV 51% · EM ±7.1%Jun 08 — IV 45% · EM ±5.9%Jun 09 — IV 47% · EM ±5.9%Jun 10 — IV 50% · EM ±5.9%Jun 11 — IV 45% · EM ±5.0%Jun 12 — IV 45% · EM ±4.6%Jun 15 — IV 55% · EM ±4.0%Jun 16 — IV 59% · EM ±3.5%Jun 17 — IV 59% · EM ±2.4%Jun 19 — IV 39% · EM ±8.5%Jun 22 — IV 38% · EM ±8.0%Jun 23 — IV 36% · EM ±7.3%Jun 24 — IV 41% · EM ±8.1%Jun 25 — IV 39% · EM ±7.7%Jun 26 — IV 38% · EM ±7.3%Jun 29 — IV 39% · EM ±6.9%Jun 30 — IV 38% · EM ±6.6%Jul 01 — IV 40% · EM ±6.7%Jul 02 — IV 38% · EM ±6.1%Jul 03 — IV 39% · EM ±6.1%Jul 06 — IV 42% · EM ±5.8%Jul 07 — IV 41% · EM ±5.4%Jul 08 — IV 43% · EM ±5.4%Jul 09 — IV 42% · EM ±5.0%Jul 10 — IV 37% · EM ±4.1%Jul 13 — IV 49% · EM ±4.1%Jul 14 — IV 54% · EM ±3.9%Jul 15 — IV 48% · EM ±2.8%Jul 16 — IV 56% · EM ±2.3%Jul 20 — IV 65% · EM ±15.4%Jul 21 — IV 67% · EM ±15.5%Jul 22 — IV 79% · EM ±18.1%Jul 23 — IV 39% · EM ±8.8%Jul 24 — IV 36% · EM ±8.0%Jul 27 — IV 37% · EM ±7.8%Jul 28 — IV 38% · EM ±7.9%Jul 29 — IV 56% · EM ±11.2%Jul 30 — IV 37% · EM ±7.2%Jul 31 — IV 37% · EM ±7.1%Aug 03 — IV 39% · EM ±6.9%Aug 04 — IV 37% · EM ±6.3%Aug 05 — IV 34% · EM ±5.6%Aug 06 — IV 36% · EM ±5.8%Aug 07 — IV 34% · EM ±5.4%Aug 10 — IV 29% · EM ±4.0%Aug 11 — IV 26% · EM ±3.4%Aug 12 — IV 28% · EM ±3.6%Aug 13 — IV 34% · EM ±4.0%Aug 14 — IV 30% · EM ±3.3%Aug 17 — IV 36% · EM ±3.0%Aug 18 — IV 35% · EM ±2.6%Aug 19 — IV 26% · EM ±1.6%Aug 20 — IV 59% · EM ±2.4%Aug 24 — IV 31% · EM ±6.5%Aug 25 — IV 32% · EM ±6.5%Aug 26 — IV 30% · EM ±6.1%Aug 27 — IV 29% · EM ±5.7%Aug 28 — IV 30% · EM ±5.8%Aug 31 — IV 33% · EM ±5.9%Sep 01 — IV 32% · EM ±5.5%Sep 02 — IV 34% · EM ±5.6%Sep 03 — IV 31% · EM ±5.1%Sep 04 — IV 39% · EM ±6.1%Sep 07 — IV 44% · EM ±6.1%Sep 08 — IV 43% · EM ±5.6%Sep 09 — IV 37% · EM ±4.6%Sep 10 — IV 36% · EM ±4.3%Sep 11 — IV 35% · EM ±3.8%Sep 14 — IV 43% · EM ±3.6%Sep 15 — IV 47% · EM ±3.4%Sep 16 — IV 42% · EM ±2.5%Sep 17 — IV 48% · EM ±2.0%Sep 21 — IV 32% · EM ±6.7%Sep 22 — IV 30% · EM ±6.1%Sep 23 — IV 31% · EM ±6.2%Sep 24 — IV 30% · EM ±5.9%Sep 25 — IV 30% · EM ±5.7%Sep 28 — IV 32% · EM ±5.7%Sep 29 — IV 33% · EM ±5.7%Sep 30 — IV 31% · EM ±5.3%Oct 01 — IV 30% · EM ±4.8%Oct 02 — IV 31% · EM ±4.9%Oct 05 — IV 35% · EM ±4.8%Oct 06 — IV 33% · EM ±4.3%Oct 07 — IV 32% · EM ±4.0%Oct 08 — IV 33% · EM ±3.8%

Sector peers

CRL
Charles River Laboratories International, Inc.
$14.3B $339.66+7.7%
ICLR
ICON plc
$12.6B $185.43+6.5%
INCY
Incyte Corporation
$23.0B $116.93+0.3%
ABSI
Absci Corporation
$1.8B $9.37+3.3%
OABI
OmniAb, Inc.
$663M $4.78-3.6%
NRC
NRC Health
$447M $21.38+3.3%

MEDP earnings FAQ

What is MEDP's expected move for earnings?

Options currently price a move of about ±3.8%, or $25.17 per share either way from $653.96.

How does MEDP stock usually react to earnings?

Across the last 6 reports the average next-day move was ±19.9%, up 3 times and down 3 times.

What is MEDP's implied volatility?

MEDP's at-the-money implied volatility is about 33% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in